Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
  1. 8-K/A Event Executive or director change
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. SC 13G Stake Amended Statement of Ownership
  5. 8-K Event Other events
  6. 4 Open-market sale Senior Vice President, R&D sold 1,563 shares at an average $21.71 ($33,940)
  7. 4 Open-market sale SVP, GC & Corporate Secretary sold 1,950 shares at an average $21.51 ($41,943)
  8. 4 Open-market sale Chief Financial Officer sold 2,200 shares at $21.51 ($47,322)
  9. 4 Open-market sale SVP, Chief Accounting Officer sold 881 shares at an average $21.72 ($19,134)
  10. 4 Grant or award Director acquired 3,000 shares (grant or award)
  11. 4 Grant or award Director acquired 3,000 shares (grant or award)
  12. 4 Open-market sale Director sold 2,575 shares at $21.92 ($56,457)
  13. 4 Grant or award Director acquired 3,000 shares (grant or award)
  14. 4 Grant or award Director acquired 3,000 shares (grant or award)
  15. 4 Grant or award Director acquired 3,000 shares (grant or award)
  16. 4 Grant or award Director acquired 3,000 shares (grant or award)
  17. 4 Grant or award Director acquired 3,000 shares (grant or award)
  18. 4 Grant or award Director acquired 3,000 shares (grant or award)
  19. 4 Grant or award Director acquired 3,000 shares (grant or award)
  20. 8-K Event Executive or director change · Shareholder vote results

Page 25 of 65 · 1,286 filings